In the realm where financial acumen blends with personal legacy planning, strategic philanthropy is offering the blueprint for modern wealth management. Today's billionaire donors are engraving ...

A return of the NHL to Atlanta looks closer than ever, and the Braves developed the blueprint that could make the third time the charm ...

No need to panic about Caleb Williams; the Chicago Bears have the blueprint to propel him into a star quarterback in Year 2.

From last place to title chase – are the South East Melbourne Phoenix on the verge of following the Illawarra Hawks’ blueprint for a championship? After five straight losses to open NBL25, the Phoenix ...

Telecom ministers adopted today the EU blueprint for cyber crisis management, which gives guidance for the EU’s response to large-scale cybersecurity incidents or cyber crises.

The blueprint for Caleb Williams to end Bears' 105-season drought, become team's first 4,000-yard passer It's all there for the former No. 1 overall pick to thrive ...

Sanofi announced that it will buy pharma company Blueprint Medicines for $129 per share, making the deal worth more than $9 billion. Blueprint specializes in systemic mastocytosis and other ...

No formal plan for Ukraine’s agricultural recovery exists today. CSIS presents a blueprint for an agricultural recovery plan that positions Ukraine’s agriculture sector for an economically competitive ...

French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for up to $9.5 billion, sending shares of the Cambridge, Mass.-based biopharma firm soaring in intraday trading.

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck by a European ...

After signaling its intent to make "bolt-on acquisitions," Sanofi has taken a major plunge, buying out Blueprint Medicines for $9.5 billion.

Cambridge-based Blueprint Medicines brings a pipeline of experimental immunology treatments and one medicine already on sale for a rare condition known as systemic mastocytosis.